{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:35:18Z","timestamp":1771878918680,"version":"3.50.1"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/100002429","name":"Amgen as Investigator sponsored study","doi-asserted-by":"publisher","award":["291397"],"award-info":[{"award-number":["291397"]}],"id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>To assess the current dyslipidemia management in the Arabian Gulf region by describing\nthe demographics, study design, and preliminary results of out-patients who achieved low-density\nlipoprotein cholesterol (LDL-C) goals at the time of the survey.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The Arabian Gulf population is at high risk for atherosclerotic cardiovascular disease at\nyounger ages. There is no up-to-date study regarding dyslipidemia management in this region, especially\ngiven the recent guideline-recommended LDL-C targets.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Up-to-date comprehensive assessment of the current dyslipidemia management in the Arabian\nGulf region, particularly in view of the recent evidence of the additive beneficial effects of ezetimibe\nand proprotein convertase subtilisin\/kexin-9 (PCSK-9) inhibitors on LDL-C levels and cardiovascular\noutcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The Gulf Achievement of Cholesterol Targets in Out-Patients (GULF ACTION) is an ongoing\nnational observational longitudinal registry of 3000 patients. In this study, adults \u226518 years on lipidlowering\ndrugs for over three months from out-patients of five Gulf countries were enrolled between\nJanuary 2020 and May 2022 with planned six-month and one-year follow-ups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Of the 1015 patients enrolled, 71% were male, aged 57.9\u00b112 years. In addition, 68% had atherosclerotic\ncardiovascular disease (ASCVD), 25% of these patients achieved the LDL-C target, and\n26% of the cohort were treated using combined lipid-lowering drugs, including statins.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The preliminary results of this cohort revealed that only one-fourth of ASCVD patients\nachieved LDL-C targets. Therefore, GULF ACTION shall improve our understanding of current\ndyslipidemia management and \u201cguideline gaps\u201d in the Arabian Gulf region.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570161121666230710145604","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:55:58Z","timestamp":1689076558000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Gulf Achievement of Cholesterol Targets in Out-Patients Study\n(GULF ACTION): Design, Rationale, and Preliminary Results"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-8204","authenticated-orcid":true,"given":"Hanan B","family":"Albackr","sequence":"first","affiliation":[{"name":"Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Al Waili","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Sultan Qaboos University, Masqat, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Almahmeed","sequence":"additional","affiliation":[{"name":"Heart Vascular Institute Cleveland Clinic Abu Dhabi, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Al","family":"Jarallah","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sabah Al Ahmad Cardiac Center, Al Amiri Hospital, Kuwait City, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad I","family":"Amin","sequence":"additional","affiliation":[{"name":"Mohamed Bin Khalifa specialist Cardiac Center, Awali, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Alrasadi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine &amp; Health Sciences, Sultan Qaboos University, Muscat, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Batais","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turky H.","family":"Almigbal","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Youssef","sequence":"additional","affiliation":[{"name":"Saud AlBabtain Cardiac Center, Dammam, Saudi Arabia"},{"name":"Department of Cardiology, Suez Canal\nUniversity, Ismailia, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, Ministry of National Guard Health Affairs, Riyadh,\nSaudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"},{"name":"King Saud bin Abdulaziz\nUniversity for health sciences, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Al Shehri","sequence":"additional","affiliation":[{"name":"Armed forces hospital, Southern Region, KSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Armed forces hospital, Southern Region, KSA"},{"name":"AL-Azhar\nUniversity Hospitals, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riham A.","family":"ElToukhy","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh,\nSaudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naji","family":"Kholaif","sequence":"additional","affiliation":[{"name":"Department of Adult Cardiology, Heart Center, King Faisal Specialist Hospital\nand Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulhalim J.","family":"Kinsara","sequence":"additional","affiliation":[{"name":"Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University\nfor Health Sciences, COM-WR, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Al-Kindi","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Royal Hospital, Muscat, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooshin","family":"Barzargani","sequence":"additional","affiliation":[{"name":"Dubai Hospital, Dubai, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy","family":"Hassan","sequence":"additional","affiliation":[{"name":"Primary Health\nCare Department, Dubai Academic Health Corporation, Dubai, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamsa Al","family":"Suwaidi","sequence":"additional","affiliation":[{"name":"Primary Health\nCare Department, Dubai Academic Health Corporation, Dubai, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Rajan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sabah Al\nAhmad Cardiac Center, Al Amiri Hospital, Kuwait City, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Altaradi","sequence":"additional","affiliation":[{"name":"King Saud University Medical City, Corporate\nof Nursing Affairs, Nursing Education and Development, Research Unit, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-3874","authenticated-orcid":true,"given":"Khalid F","family":"Alhabib","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University Medical\nCity, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/235101","volume":"2015","author":"Aljefree N.","year":"2015","unstructured":"Aljefree N.; Ahmed F.; Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: A systematic review. Adv Public Health 2015,2015,1-23","journal-title":"Adv Public Health"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1185\/03007995.2014.965774","volume":"30","author":"Al-Rasadi K.","year":"2014","unstructured":"Al-Rasadi K.; Al-Zakwani I.; Al Mahmeed W.; Therapeutic lipid target achievements among high and highest risk patients: Results from the CEPHEUS study in the Arabian Gulf. Curr Med Res Opin 2014,30(12),2429-2435","journal-title":"Curr Med Res Opin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","volume":"74","author":"Arnett D.K.","year":"2019","unstructured":"Arnett D.K.; Blumenthal R.S.; Albert M.A.; 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease. J Am Coll Cardiol 2019,74(10),e177-e232","journal-title":"J Am Coll Cardiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"Mach F.","year":"2020","unstructured":"Mach F.; Baigent C.; Catapano A.L.; 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 2020,41(1),111-188","journal-title":"Eur Heart J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"Sabatine M.S.","year":"2017","unstructured":"Sabatine M.S.; Giugliano R.P.; Keech A.C.; Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017,376(18),1713-1722","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.12688\/wellcomeopenres.15829.2","volume":"5","author":"Chacko M.","year":"2020","unstructured":"Chacko M.; Sarma P.S.; Harikrishnan S.; Zachariah G.; Jeemon P.; Family history of cardiovascular disease and risk of premature coronary heart disease: A matched case-control study. Wellcome Open Res 2020,5,70","journal-title":"Wellcome Open Res"},{"key":"ref=7","first-page":"19","volume":"2013","year":"2011","unstructured":"Chapter 1: Definition and classification of CKD. Kidney Int Suppl 2011,2013(3),19-62","journal-title":"Kidney Int Suppl"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/MOL.0b013e32800ff750","volume":"17","author":"Brown B.G.","year":"2006","unstructured":"Brown B.G.; Stukovsky K.H.; Zhao X.Q.; Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: A meta-analysis of 23 randomized lipid trials. Curr Opin Lipidol 2006,17(6),631-636","journal-title":"Curr Opin Lipidol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","volume":"48","author":"Cannon C.P.","year":"2006","unstructured":"Cannon C.P.; Steinberg B.A.; Murphy S.A.; Mega J.L.; Braunwald E.; Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006,48(3),438-445","journal-title":"J Am Coll Cardiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1136\/bmj.38793.468449.AE","volume":"332","author":"Costa J.","year":"2006","unstructured":"Costa J.; Borges M.; David C.; Carneiro A.V.; Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Metaanalysis of randomised controlled trials. BMJ 2006,332(7550),1115-1124","journal-title":"BMJ"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2143\/AC.64.4.2041607","volume":"64","author":"Zubaid M.","year":"2009","unstructured":"Zubaid M.; Rashed W.A.; Almahmeed W.; Management and outcomes of Middle Eastern patients admitted with acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE). Acta Cardiol 2009,64(4),439-446","journal-title":"Acta Cardiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e0216551","DOI":"10.1371\/journal.pone.0216551","volume":"14","author":"Alhabib K.F.","year":"2019","unstructured":"Alhabib K.F.; Kinsara A.J.; Alghamdi S.; The first survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and long-term outcomes (STARS-1 Program). PLoS One 2019,14(5),e0216551","journal-title":"PLoS One"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/2047487312465525","volume":"21","author":"Gehani A.A.","year":"2014","unstructured":"Gehani A.A.; Al-Hinai A.T.; Zubaid M.; Association of risk factors with acute myocardial infarction in Middle Eastern countries: The INTERHEART Middle East study. Eur J Prev Cardiol 2014,21(4),400-410","journal-title":"Eur J Prev Cardiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e0251560","DOI":"10.1371\/journal.pone.0251560","volume":"16","author":"Alhabib K.F.","year":"2021","unstructured":"Alhabib K.F.; Al-Rasadi K.; Almigbal T.H.; Familial hypercholesterolemia in the Arabian gulf region: Clinical results of the gulf FH registry. PLoS One 2021,16(6),e0251560","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"83S-9S","DOI":"10.1177\/1010539510373034","volume":"22","author":"Ramahi TM","year":"2010","unstructured":"Ramahi TM; Cardiovascular disease in the Asia Middle East region: Global trends and local implications. Asia Pac J Public Health 2010,22(3_suppl)(Suppl.),83S-9S","journal-title":"Asia Pac J Public Health"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrcardio.2017.138","volume":"15","author":"Turk-Adawi K.","year":"2018","unstructured":"Turk-Adawi K.; Sarrafzadegan N.; Fadhil I.; Cardiovascular disease in the Eastern Mediterranean region: Epidemiology and risk factor burden. Nat Rev Cardiol 2018,15(2),106-119","journal-title":"Nat Rev Cardiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1186\/s12889-020-09298-w","volume":"20","author":"Alhabib K.F.","year":"2020","unstructured":"Alhabib K.F.; Batais M.A.; Almigbal T.H.; Demographic, behavioral, and cardiovascular disease risk factors in the Saudi population: Results from the Prospective Urban Rural Epidemiology study (PURE-Saudi). BMC Public Health 2020,20(1),1213","journal-title":"BMC Public Health"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e84350","DOI":"10.1371\/journal.pone.0084350","volume":"9","author":"Al Sifri S.N.","year":"2014","unstructured":"Al Sifri S.N.; Almahmeed W.; Azar S.; Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment. PLoS One 2014,9(1),e84350","journal-title":"PLoS One"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/0003319713512414","volume":"65","author":"Arafah M.","year":"2014","unstructured":"Arafah M.; Al-Hinai A.T.; Mahmeed W.A.; Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia: Results from the CEPHEUS study in Arabian Gulf countries. Angiology 2014,65(10),919-926","journal-title":"Angiology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/HJR.0b013e3283383f30","volume":"17","author":"Kotseva K.","year":"2010","unstructured":"Kotseva K.; Wood D.; De Backer G.; EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: Cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil 2010,17(5),530-540","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","volume":"28","author":"Ray K.K.","year":"2021","unstructured":"Ray K.K.; Molemans B.; Schoonen W.M.; EU-Wi de cross-section al observational study of lipid-modifying therapy use in secondary and primary care: The DA VINCI study. Eur J Prev Cardiol 2021,28(11),1279-1289","journal-title":"Eur J Prev Cardiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"Catapano A.L.","year":"2016","unstructured":"Catapano A.L.; Graham I.; De Backer G.; 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2016,37(39),2999-3058","journal-title":"Eur Heart J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"100624","DOI":"10.1016\/j.lanepe.2023.100624","volume":"29","author":"Ray K.K.","year":"2023","unstructured":"Ray K.K.; Haq I.; Bilitou A.; Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: The multinational observational SANTORINI study. Lancet Reg Health Eur 2023,29,100624","journal-title":"Lancet Reg Health Eur"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","volume":"8","author":"Grundy S.M.","year":"2014","unstructured":"Grundy S.M.; Arai H.; Barter P.; An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report. J Clin Lipidol 2014,8(1),29-60","journal-title":"J Clin Lipidol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1177\/2047487318777079","volume":"25","author":"Danchin N.","year":"2018","unstructured":"Danchin N.; Almahmeed W.; Al-Rasadi K.; Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). Eur J Prev Cardiol 2018,25(10),1087-1094","journal-title":"Eur J Prev Cardiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","volume":"124","author":"Ward N.C.","year":"2019","unstructured":"Ward N.C.; Watts G.F.; Eckel R.H.; Statin toxicity. Circ Res 2019,124(2),328-350","journal-title":"Circ Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/eurheartj\/ehab718","volume":"43","author":"Ray K.K.","year":"2022","unstructured":"Ray K.K.; Reeskamp L.F.; Laufs U.; Combination lipid-lowering therapy as first-line strategy in very high-risk patients. Eur Heart J 2022,43(8),830-833","journal-title":"Eur Heart J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/eurheartj\/ehaa1008","volume":"42","author":"Ray K.K.","year":"2021","unstructured":"Ray K.K.; Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care. Eur Heart J 2021,42(3),253-256","journal-title":"Eur Heart J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"Cannon C.P.","year":"2015","unstructured":"Cannon C.P.; Blazing M.A.; Giugliano R.P.; Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015,372(25),2387-2397","journal-title":"N Engl J Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","volume":"400","author":"Kim B.K.","year":"2022","unstructured":"Kim B.K.; Hong S.J.; Lee Y.J.; Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): A randomised, open-label, non-inferiority trial. Lancet 2022,400(10349),380-390","journal-title":"Lancet"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"789931","DOI":"10.3389\/fcvm.2021.789931","volume":"8","author":"Bardolia C.","year":"2021","unstructured":"Bardolia C.; Amin N.S.; Turgeon J.; Emerging non-statin treatment options for lowering low-density lipoprotein cholesterol. Front Cardiovasc Med 2021,8,789931","journal-title":"Front Cardiovasc Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4330\/wjc.v9.i2.76","volume":"9","author":"Chaudhary R.","year":"2017","unstructured":"Chaudhary R.; Garg J.; Shah N.; Sumner A.; PCSK9 inhibitors: A new era of lipid lowering therapy. World J Cardiol 2017,9(2),76-91","journal-title":"World J Cardiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","volume":"382","author":"Ray K.K.","year":"2020","unstructured":"Ray K.K.; Wright R.S.; Kallend D.; Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med 2020,382(16),1507-1519","journal-title":"N Engl J Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12933-023-01752-4","volume":"22","author":"Nishikido T.","year":"2023","unstructured":"Nishikido T.; Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease. Cardiovasc Diabetol 2023,22(1),20","journal-title":"Cardiovasc Diabetol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fca-2020-0150","volume":"17","author":"Brandts J.","year":"2021","unstructured":"Brandts J.; Ray K.K.; Clinical implications and outcomes of the ORION Phase III trials. Future Cardiol 2021,17(5),769-777","journal-title":"Future Cardiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/eurheartj\/ehac594","volume":"44","author":"Ray K.K.","year":"2023","unstructured":"Ray K.K.; Raal F.J.; Kallend D.G.; Inclisiran and cardiovascular events: A patient-level analysis of phase III trials. Eur Heart J 2023,44(2),129-138","journal-title":"Eur Heart J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1803917","volume":"380","author":"Ray K.K.","year":"2019","unstructured":"Ray K.K.; Bays H.E.; Catapano A.L.; Safety and efficacy of bempedoic acid to reduce LDL cholesterol. N Engl J Med 2019,380(11),1022-1032","journal-title":"N Engl J Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/13543784.2017.1280458","volume":"26","author":"Penson P.","year":"2017","unstructured":"Penson P.; McGowan M.; Banach M.; Evaluating bempedoic acid for the treatment of hyperlipidaemia. Expert Opin Investig Drugs 2017,26(2),251-259","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=39","first-page":"00026-9","volume":"S0033-0620","author":"Banach M","year":"2023","unstructured":"Banach M; Penson PE; Farnier M; Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP). Prog Cardiovasc Dis 2023,S0033-0620(23),00026-9","journal-title":"Prog Cardiovasc Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"Nissen S.E.","year":"2023","unstructured":"Nissen S.E.; Lincoff A.M.; Brennan D.; Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med 2023,388(15),1353-1364","journal-title":"N Engl J Med"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570161121666230710145604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/218598\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570161121666230710145604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:21:20Z","timestamp":1697631680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/218598\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161121666230710145604","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}